Clinical trials recruiting for Early Breast Cancer

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
  NCT07310420 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: Female · 20 locations
• Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
  NCT06650423 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: Female · 1 location
• Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers
  NCT07233928 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
  NCT06341894 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
  NCT07405931 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 5 locations
• Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer
  NCT06984250 · Phase: Not specified · Ages: 20 Years to 85 Years · Sex: Female · 2 locations
• Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)
  NCT06928701 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC
  NCT07327021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Mediterranean Diet and Inequality in Early Breast Cancer
  NCT07007169 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
  NCT07106632 · Phase: Phase 3 · Ages: 35 Years to 45 Years · Sex: Female · 105 locations
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
  NCT05827081 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 229 locations
• Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer
  NCT07579286 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female · 1 location
• The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
  NCT04291378 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 8 locations

Related conditions

Trials recruiting for Early Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Early Breast Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.